Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 173

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma

Open access
Liao, Rui, Sun, Jian, Wu, Han, Yi, Yong, Wang, Jia-Xing, He, Hong-Wei, Cai, Xiao-Yan, Zhou, Jian, Cheng, Yun-Feng, Fan, Jia, Qiu, Shuang-Jian · 2013 · Journal of Experimental & Clinical Cancer Research

Abstract

Background: Hepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of infiltrating inflammatory/immune cells in HCC and can amplify inflammatory response via binding to interleukin-17 receptor (IL-17R). Thus, we investigated the expression and clinical significance of IL-17 and IL-17 receptor family cytokines in HCC. Methods: The expression and prognostic value of IL-17 and IL-17R (A-E) were examined in 300 HCC patients after resection. Six Th17 associated cytokines in serum (n = 111) were quantified using enzyme-linked immunosorbent assays. Phenotypic features of IL-17+ CD4+ T cells were determined by flow cytometry analysis. Results: High expression of intratumoral IL-17 and IL1-7RE were significantly associated with poorer survival (p = 0.016 and <0.001, respectively) and increased recurrence (both P < 0.001) of HCC patients. Moreover, intratumoral IL-17, individually or synergistically with IL-17RE, could predict HCC early recurrence and late recurrence. Also, peritumoral IL-17RE showed the prognostic ability in HCC (P < 0.001 for OS/TTR). Furthermore, expression levels of Th17 associated cytokines including IL-6, -22, -17R and TNF-α were increased in serum of HCC patients compared to haemangioma patients. Importantly, activated human hepatic stellate cells induced in vitro expansion of IL-17+ CD4+ T cells. Conclusions: High expression of IL-17 and IL-17RE were promising predictors for poor outcome of HCC patients. The protumor power of IL-17 producing CD4+ T cells was probably involved in the crosstalk with different types of inflammatory/immune cells in HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1756-9966-32-3

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 173

Metadata

Authors
Liao, R., Sun, J., Wu, H., Yi, Y., Wang, J.-X., He, H.-W., Cai, X.-Y., Zhou, J., Cheng, Y.-F., Fan, J., & Qiu, S.-J.
Venue
Journal of Experimental & Clinical Cancer Research
Published
2013-01-11
Volume
32
Issue
1
Pages
3-3
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W2127401224
Cited by
173
References
12
FWCI
8.44
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1186/1756-9966-32-3
The paper
Liao, R., Sun, J., Wu, H., Yi, Y., Wang, J.-X., He, H.-W., Cai, X.-Y., Zhou, J., Cheng, Y.-F., Fan, J., & Qiu, S.-J. (2013). High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/1756-9966-32-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.